Abstract:BACKGROUND:There is no research, either at home or abroad, focusing on assessing the cardiopulmonary functional reserve and exercise tolerance in patients with pulmonary embolism (PE), but the benefits of early exercise are well recognized. The goals of this study were to assess cardiopulmonary functional reserve in treated PE patients using the inert gas rebreathing method of the cardiopulmonary exercise test (CPET), and to compare it with traditional methods.METHODS:CPET on the bicycle ergometer were performed in 40 patients with age, gender, body mass index, systolic blood pressure, and pulmonary function matched. The first group was the PE group composed of 16 PE patients (5 male, 11 female) who were given the standard antithrombotic therapy for two weeks. The second group was composed of 24 normal individuals (10 male, 14 female). Both groups were evaluated by cardiac ultrasound examination, 6-minute walking test (6MWT), and CPET.RESULTS:(1) Right ventricular systolic pressure (RVSP) in the PE group increased significantly compared to the control group, (34.81 ± 8.15) mmHg to (19.75 ± 3.47) mmHg (P < 0.01). But neither right atrial end-systolic diameter (RASD) nor right ventricular end-diastolic diameter (RVDD) in the PE patients had changed when compared with the controls. The 6-minute walk distance was significantly reduced in the PE patients compared with normal subjects, (447.81 ± 79.20) m vs. (513.75 ± 31.45) m (P < 0.01). Both anaerobic threshold oxygen consumption (VO(2)AT) and peak oxygen consumption (VO(2)peak) were significantly lower in patients with PE, while CO(2) equivalent ventilation (VE/VCO(2) slope) was higher; VO(2)AT (9.44 ± 3.82) ml×kg(-1)×min(-1) vs. (14.62 ± 2.93) ml×kg(-1)×min(-1) (P < 0.01) and VO2peak (12.26 ± 4.06) ml×kg(-1)×min(-1) vs. (23.46 ± 6.15) ml×kg(-1)×min(-1) (P < 0.01) and VE/VCO(2) slope 35.47 ± 6.66 vs. 26.94 ± 3.16 (P < 0.01). There was no significant difference in resting cardiac output (CO) between the PE and normal groups, whereas peak cardiac output (peak CO) and the difference between exercise and resting cardiac output (ΔCO) were both significantly reduced in the PE group; peak CO (5.97 ± 2.25) L/min to (8.50 ± 3.13) L/min (P < 0.01), ΔCO (1.29 ± 1.59) L/min to (3.97 ± 2.02) L/min (P < 0.01). (2) The 6-minute walk distance did not correlated with CPET except for the VO2 peak in patients with PE, r = 0.675 (P < 0.01).CONCLUSIONS:The cardiopulmonary functional reserve was reduced in patients with PE. CPET is an accurate, quantitative evaluation of cardiopulmonary functional reserve for PE patients.

The value of S_ⅠQ_ⅢT_Ⅲ change for predicting cardiac-pulmonary function in patients with chronic pulmonary artery hypertension

[Reduced Cardiopulmonary Exercise Capacity in Patients with Chronic Heart Failure: Impact of Left Ventricular Systolic Dysfunction].

Role of anaerobic threshold in cardiac functional classification for NYHAⅠ-Ⅲ patients with chronic heart failure

Study on exercise capacity in patients with different types of pulmonary hypertension

Prognostic value of peak VO2 and anaerobic threshold for chronic heart failure patients

Quantitative Evaluation of Cardiopulmonary Functional Reserve in Treated Patients with Pulmonary Embolism

The efficacy of different training programs guided by cardiopulmonary exercise test goals for the treatment of male patients with chronic obstructive pulmonary disease

[End Tidal PCO(2) for Evaluation of Severity of Disease in Idiopathic Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension].

The Value of Cardiopulmonary Exercise Testing in Evaluating Group A of Chronic Obstructive Pulmonary Disease

The predictive value of minute ventilation versus carbon dioxide production in pulmonary hypertension associated with left heart disease

Early Detection of Cardiac Dysfunction in Stable Chronic Obstructive Pulmonary Disease Patients

Exercise Capacity and Ventilatory Efficiency in COPD Patients with and Without Pulmonary Hypertension

Value of Ventilation/ Perfusion SPECT in Evaluation of Anticoagulant Therapy for Patients with Pul-Monary Embolism and the Influencing Factors of Treatment Effect

The Diagnostic Value of Pulmonary Artery CT Imaging for HFpEF

Pulmonary function testing in patients with pulmonary arterial hypertension.

Changing Characteristics of Cardiopulmonary Exercise Test in Chronic Obstructive Pulmonary Diseases Patients when Peak Exercising

Cardiopulmonary Exercise Testing Combined with Haemodynamics for the Prediction of Outcome in Idiopathic Pulmonary Arterial Hypertension

Echocardiographic assessment for cardiopulmonary function in patients with congenital heart disease-related pulmonary arterial hypertension

Echocardiogram in Assessing Right Ventricular Function in Connective Tissue Diseases Combined with Pulmonary Arterial Hypertension

Cardiopulmonary Exercise Testing and Pulmonary Function Testing for Predicting the Severity of CTEPH

Diagnostic Value of Electrocardiogram in Pulmonary Artery Hypertension